Skip to main content
Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases 6/2021

06.01.2021 | Original Article

Secular trends in the epidemiology and clinical characteristics of Enterococcus faecalis infective endocarditis at a referral center (2007–2018)

verfasst von: Laura Escolà-Vergé, Nuria Fernández-Hidalgo, María Nieves Larrosa, Ruben Fernandez-Galera, Benito Almirante

Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases | Ausgabe 6/2021

Einloggen, um Zugang zu erhalten

Abstract

The aim of the study was to analyze the epidemiological and clinical changes in EFIE. All definite IE episodes treated at a referral center between 2007 and 2018 were registered prospectively, and a trend test was used to study etiologies over time. EFIE cases were divided into three periods, and clinical differences between them were analyzed. All episodes of E. faecalis monomicrobial bacteremia (EFMB) between 2010 and 2018 and the percentage of echocardiograms performed were retrospectively collected. Six hundred forty-eight IE episodes were studied. We detected an increase in the percentage of EFIE (15% in 2007, 25.3% in 2018, P = 0.038), which became the most prevalent causative agent of IE during the last study period. One hundred and eight EFIE episodes were analyzed (2007–2010, n = 30; 2011–2014, n = 22; 2015–2018, n = 56). The patients in the last period were older (median 70.9 vs 66.5 vs 76.3 years, P = 0.015) and more frequently had an abdominal origin of EFIE (20% vs 13.6% vs 42.9%, P = 0.014), fewer indications for surgery (63.3% vs 54.6% vs 32.1%, P = 0.014), and non-significantly lower in-hospital mortality (30% vs 18.2% vs 12.5%, P = 0.139). There was an increase in the percentage of echocardiograms performed in patients with EFMB (30% in 2010, 51.2% in 2018, P = 0.014) and EFIE diagnoses (15% in 2010, 32.6% in 2018, P = 0.004). E. faecalis is an increasing cause of IE in our center, most likely due to an increase in the percentage of echocardiograms performed. The factors involved in clinical changes in EFIE should be thoroughly studied.
Literatur
1.
Zurück zum Zitat Selton-Suty C, Célard M, Le Moing V et al (2012) Preeminence of Staphylococcus aureus in infective endocarditis: a 1-year population-based survey. Clin Infect Dis 54:1230–1239CrossRef Selton-Suty C, Célard M, Le Moing V et al (2012) Preeminence of Staphylococcus aureus in infective endocarditis: a 1-year population-based survey. Clin Infect Dis 54:1230–1239CrossRef
2.
Zurück zum Zitat Chirouze C, Athan E, Alla F et al (2013) Enterococcal endocarditis in the beginning of the 21st century: analysis from the International Collaboration on Endocarditis-Prospective Cohort Study. Clin Microbiol Infect 19:1140–1147CrossRef Chirouze C, Athan E, Alla F et al (2013) Enterococcal endocarditis in the beginning of the 21st century: analysis from the International Collaboration on Endocarditis-Prospective Cohort Study. Clin Microbiol Infect 19:1140–1147CrossRef
3.
Zurück zum Zitat Muñoz P, Kestler M, De Alarcon A et al (2015) Current epidemiology and outcome of infective endocarditis. Medicine (Baltimore) 94:e1816CrossRef Muñoz P, Kestler M, De Alarcon A et al (2015) Current epidemiology and outcome of infective endocarditis. Medicine (Baltimore) 94:e1816CrossRef
4.
Zurück zum Zitat Fernández-Hidalgo N, Almirante B, Tornos P et al (2008) Contemporary epidemiology and prognosis of health care–associated infective endocarditis. Clin Infect Dis 47:1287–1297CrossRef Fernández-Hidalgo N, Almirante B, Tornos P et al (2008) Contemporary epidemiology and prognosis of health care–associated infective endocarditis. Clin Infect Dis 47:1287–1297CrossRef
5.
Zurück zum Zitat Wright A, Otome O, Harvey C, Bowe S, Athan E (2018) The current epidemiology of injecting drug use-associated infective endocarditis in Victoria, Australia in the midst of increasing crystal methamphetamine use. Heart Lung Circ 27:484–488CrossRef Wright A, Otome O, Harvey C, Bowe S, Athan E (2018) The current epidemiology of injecting drug use-associated infective endocarditis in Victoria, Australia in the midst of increasing crystal methamphetamine use. Heart Lung Circ 27:484–488CrossRef
6.
Zurück zum Zitat Olmos C, Vilacosta I, Fernández-Pérez C et al (2017) The evolving nature of infective endocarditis in Spain: a population-based study (2003 to 2014). J Am Coll Cardiol 70:2795–2804CrossRef Olmos C, Vilacosta I, Fernández-Pérez C et al (2017) The evolving nature of infective endocarditis in Spain: a population-based study (2003 to 2014). J Am Coll Cardiol 70:2795–2804CrossRef
7.
Zurück zum Zitat Østergaard L, Bruun NE, Voldstedlund M et al (2019) Prevalence of infective endocarditis in patients with positive blood cultures: a Danish nationwide study. Eur Heart J 40:3237–3244CrossRef Østergaard L, Bruun NE, Voldstedlund M et al (2019) Prevalence of infective endocarditis in patients with positive blood cultures: a Danish nationwide study. Eur Heart J 40:3237–3244CrossRef
8.
Zurück zum Zitat Dahl A, Iversen K, Tonder N et al (2019) Prevalence of infective endocarditis in Enterococcus faecalis bacteremia. J Am Coll Cardiol 74:193–201CrossRef Dahl A, Iversen K, Tonder N et al (2019) Prevalence of infective endocarditis in Enterococcus faecalis bacteremia. J Am Coll Cardiol 74:193–201CrossRef
9.
Zurück zum Zitat Fernández-Hidalgo N, Escolà-Vergé L (2019) Enterococcus faecalis bacteremia: consider an echocardiography, but consult an infectious diseases specialist. J Am Coll Cardiol 74:202–204CrossRef Fernández-Hidalgo N, Escolà-Vergé L (2019) Enterococcus faecalis bacteremia: consider an echocardiography, but consult an infectious diseases specialist. J Am Coll Cardiol 74:202–204CrossRef
10.
Zurück zum Zitat Habib G, Erba PA, Iung B et al (2019) Clinical presentation, aetiology and outcome of infective endocarditis. Results of the ESC-EORP EURO-ENDO (European infective endocarditis) registry: a prospective cohort study. Eur Heart J 40:3222–3232CrossRef Habib G, Erba PA, Iung B et al (2019) Clinical presentation, aetiology and outcome of infective endocarditis. Results of the ESC-EORP EURO-ENDO (European infective endocarditis) registry: a prospective cohort study. Eur Heart J 40:3222–3232CrossRef
11.
Zurück zum Zitat Pizzi MN, Roque A, Fernández-Hidalgo N et al (2015) Improving the diagnosis of infective endocarditis in prosthetic valves and intracardiac devices with 18F-Fluordeoxyglucose positron emission tomography/computed tomography angiography: initial results at an infective endocarditis referral center. Circulation 132:1113–1126CrossRef Pizzi MN, Roque A, Fernández-Hidalgo N et al (2015) Improving the diagnosis of infective endocarditis in prosthetic valves and intracardiac devices with 18F-Fluordeoxyglucose positron emission tomography/computed tomography angiography: initial results at an infective endocarditis referral center. Circulation 132:1113–1126CrossRef
12.
Zurück zum Zitat Escolà-Vergé L, Peghin M, Givone F et al (2020) Prevalence of colorectal disease in Enterococcus faecalis infective endocarditis: results of an observational multicenter study. Rev Esp Cardiol (Engl Ed) 73(9):711–717 Escolà-Vergé L, Peghin M, Givone F et al (2020) Prevalence of colorectal disease in Enterococcus faecalis infective endocarditis: results of an observational multicenter study. Rev Esp Cardiol (Engl Ed) 73(9):711–717
13.
Zurück zum Zitat Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373–383CrossRef Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373–383CrossRef
14.
Zurück zum Zitat Li JS, Sexton DJ, Mick N et al (2000) Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 30:633–638CrossRef Li JS, Sexton DJ, Mick N et al (2000) Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 30:633–638CrossRef
15.
Zurück zum Zitat Habib G, Lancellotti P, Antunes MJ et al (2015) 2015 ESC guidelines for the management of infective endocarditis: the task force for the management of infective endocarditis of the European Society of Cardiology (ESC) endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J 36:3075–3128CrossRef Habib G, Lancellotti P, Antunes MJ et al (2015) 2015 ESC guidelines for the management of infective endocarditis: the task force for the management of infective endocarditis of the European Society of Cardiology (ESC) endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J 36:3075–3128CrossRef
16.
Zurück zum Zitat Benito N, Miró JM, de Lazzari E et al (2009) Health care–associated native valve endocarditis in patients with no history of injection drug use: current importance of non-nosocomial acquisition. Ann Intern Med 150:586–594CrossRef Benito N, Miró JM, de Lazzari E et al (2009) Health care–associated native valve endocarditis in patients with no history of injection drug use: current importance of non-nosocomial acquisition. Ann Intern Med 150:586–594CrossRef
17.
Zurück zum Zitat Horstkotte D (2004) Guidelines on prevention, diagnosis and treatment of infective endocarditis executive summary the task force on infective endocarditis of the European Society of Cardiology. Eur Heart J 25:267–276CrossRef Horstkotte D (2004) Guidelines on prevention, diagnosis and treatment of infective endocarditis executive summary the task force on infective endocarditis of the European Society of Cardiology. Eur Heart J 25:267–276CrossRef
18.
Zurück zum Zitat Habib G, Hoen B, Tornos P et al (2009) Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the task force on the prevention, diagnosis, and treatment of infective endocarditis of the European Society of Cardiology (ESC). Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and by the International Society of Chemotherapy (ISC) for infection and cancer. Eur Heart J 30:2369–2413CrossRef Habib G, Hoen B, Tornos P et al (2009) Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the task force on the prevention, diagnosis, and treatment of infective endocarditis of the European Society of Cardiology (ESC). Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and by the International Society of Chemotherapy (ISC) for infection and cancer. Eur Heart J 30:2369–2413CrossRef
19.
Zurück zum Zitat Levy MM, Fink MP, Marshall JC et al (2003) 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 31:1250–1256CrossRef Levy MM, Fink MP, Marshall JC et al (2003) 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 31:1250–1256CrossRef
20.
Zurück zum Zitat Kellum JA, Levin N, Bouman C, Lameire N (2002) Developing a consensus classification system for acute renal failure. Curr Opin Crit Care 8:509–514CrossRef Kellum JA, Levin N, Bouman C, Lameire N (2002) Developing a consensus classification system for acute renal failure. Curr Opin Crit Care 8:509–514CrossRef
21.
Zurück zum Zitat Bouza E, Kestler M, Beca T et al (2015) The NOVA score: a proposal to reduce the need for transesophageal echocardiography in patients with enterococcal bacteremia. Clin Infect Dis 60:528–535CrossRef Bouza E, Kestler M, Beca T et al (2015) The NOVA score: a proposal to reduce the need for transesophageal echocardiography in patients with enterococcal bacteremia. Clin Infect Dis 60:528–535CrossRef
22.
Zurück zum Zitat Berge A, Krantz A, Östlund H, Nauclér P, Rasmussen M (2019) The DENOVA score efficiently identifies patients with monomicrobial Enterococcus faecalis bacteremia where echocardiography is not necessary. Infection 47:45–50CrossRef Berge A, Krantz A, Östlund H, Nauclér P, Rasmussen M (2019) The DENOVA score efficiently identifies patients with monomicrobial Enterococcus faecalis bacteremia where echocardiography is not necessary. Infection 47:45–50CrossRef
23.
Zurück zum Zitat Forestier E, Roubaud-Baudron C, Fraisse T et al (2019) Comprehensive geriatric assessment in older patients suffering from infective endocarditis. A prospective multicentric cohort study. Clin Microbiol Infect 25:1246–1252CrossRef Forestier E, Roubaud-Baudron C, Fraisse T et al (2019) Comprehensive geriatric assessment in older patients suffering from infective endocarditis. A prospective multicentric cohort study. Clin Microbiol Infect 25:1246–1252CrossRef
24.
Zurück zum Zitat Fernández-Hidalgo N, Almirante B, Gavaldà J et al (2013) Ampicillin plus ceftriaxone is as effective as ampicillin plus gentamicin for treating Enterococcus faecalis infective endocarditis. Clin Infect Dis 56:1261–1268CrossRef Fernández-Hidalgo N, Almirante B, Gavaldà J et al (2013) Ampicillin plus ceftriaxone is as effective as ampicillin plus gentamicin for treating Enterococcus faecalis infective endocarditis. Clin Infect Dis 56:1261–1268CrossRef
25.
Zurück zum Zitat Escolà-Vergé L, Fernández-Hidalgo N, Rodríguez-Pardo D et al (2019) Teicoplanin for treating enterococcal infective endocarditis: a retrospective observational study from a referral centre in Spain. Int J Antimicrob Agents 53:165–170CrossRef Escolà-Vergé L, Fernández-Hidalgo N, Rodríguez-Pardo D et al (2019) Teicoplanin for treating enterococcal infective endocarditis: a retrospective observational study from a referral centre in Spain. Int J Antimicrob Agents 53:165–170CrossRef
26.
Zurück zum Zitat Fernández-Hidalgo N, Almirante B, Tornos P et al (2011) Prognosis of left-sided infective endocarditis in patients transferred to a tertiary-care hospital--prospective analysis of referral bias and influence of inadequate antimicrobial treatment. Clin Microbiol Infect 17:769–775CrossRef Fernández-Hidalgo N, Almirante B, Tornos P et al (2011) Prognosis of left-sided infective endocarditis in patients transferred to a tertiary-care hospital--prospective analysis of referral bias and influence of inadequate antimicrobial treatment. Clin Microbiol Infect 17:769–775CrossRef
Metadaten
Titel
Secular trends in the epidemiology and clinical characteristics of Enterococcus faecalis infective endocarditis at a referral center (2007–2018)
verfasst von
Laura Escolà-Vergé
Nuria Fernández-Hidalgo
María Nieves Larrosa
Ruben Fernandez-Galera
Benito Almirante
Publikationsdatum
06.01.2021
Verlag
Springer Berlin Heidelberg
Erschienen in
European Journal of Clinical Microbiology & Infectious Diseases / Ausgabe 6/2021
Print ISSN: 0934-9723
Elektronische ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-020-04117-x

Weitere Artikel der Ausgabe 6/2021

European Journal of Clinical Microbiology & Infectious Diseases 6/2021 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.